Azora Therapeutics, Inc. (DE) (AZR) — Institutional Holders, Q3 2026

22 institutional investment managers reported a AZR position on SEC Form 13F-HR for the quarter ended September 30, 2026, with a combined reported value of $2.8M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

AZR in Q3 2026: what funds did

Funds that filed a 13F for both Q2 2026 and Q3 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

7

Added to

7

Trimmed

2

Sold out

3

Biggest buyers

  1. KVP Capital AdvisorsNew · +210,256 sh+$843.1K
  2. DIADEMA PARTNERSNew · +181,890 sh+$729.4K
  3. ACUTA CAPITAL PARTNERSNew · +129,982 sh+$521.2K
  4. XTX Topco LtdNew · +26,771 sh+$107.4K
  5. JANE STREET GROUPAdded · +21,833 sh+$87.6K

Biggest sellers

  1. Stonepine Capital ManagementSold out · -727,563 sh-$2.9M
  2. StoneX GroupSold out · -19,699 sh-$79.0K
  3. UBS Group AGTrimmed · -17,459 sh-$70.0K
  4. HARBOUR INVESTMENTSSold out · -3 sh-$12.00
  5. SBI Securities , Ltd.Trimmed · -2 sh-$8.00

AZR 13F holders ranked 1–22 of 22

Institutional investors reporting a position in Azora Therapeutics, Inc. (DE) on SEC Form 13F-HR for Q3 2026, ranked by reported value.
InstitutionValueQoQ
KVP Capital Advisors#1 · 210,256 sh$843.1KNew
DIADEMA PARTNERS#2 · 181,890 sh$729.4KNew
ACUTA CAPITAL PARTNERS#3 · 129,982 sh$521.2KNew
JANE STREET GROUP#4 · 53,952 sh$216.3K+68.0%
CITADEL ADVISORS#5 · 29,753 sh$119.3K+0.7%
XTX Topco Ltd#6 · 26,771 sh$107.4KNew
GEODE CAPITAL MANAGEMENT#7 · 21,546 sh$86.4K+73.9%
VANGUARD FIDUCIARY#8 · 15,879 sh$63.7K+170.1%
China Universal Asset Management , Ltd.#9 · 12,800 sh$53.1K+60.0%
VANGUARD CAPITAL MANAGEMENT#10 · 10,407 sh$41.7K+78.5%
Manchester Capital Management#11 · 1,923 sh$7.7K0.0%
Tower Research Capital (TRC)#12 · 1,777 sh$7.1K+25.2%
UBS Group AG#13 · 1,688 sh$6.8K-91.2%
BARCLAYS PLC#14 · 1,094 sh$4.4KNew
BlackRock#15 · 304 sh$1.2K0.0%
RAFFA WEALTH MANAGEMENT#16 · 83 sh$333.000.0%
MORGAN STANLEY#17 · 50 sh$201.000.0%
SBI Securities , Ltd.#18 · 45 sh$180.00-4.3%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT#19 · 30 sh$120.00New
Caitong International Asset Management , Ltd#20 · 9 sh$36.00New
WELLS FARGO & COMPANY#21 · 6 sh$24.000.0%
Abound Wealth Management#22 · 1 sh$5.000.0%

Funds that sold out of AZR in Q3 2026 (3)

Held AZR at the end of Q2 2026 and filed a Q3 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held AZR in Q2 2026 and reported no position in Q3 2026.
InstitutionValue in Q2 2026
Stonepine Capital Management727,563 sh$1.6M
StoneX Group19,699 sh$35.7K
HARBOUR INVESTMENTS3 sh$8.00

Source: Form 13F-HR filings on SEC EDGAR, Q3 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q2 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.